These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7112580)

  • 1. Preclinical evaluation of monkeys of a ribavirin regimen proposed for use in Lassa fever patients.
    Wannarka GL; Stephen EL; Canonico PG
    Toxicol Appl Pharmacol; 1982 Jun; 64(1):155-9. PubMed ID: 7112580
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental Lassa fever virus infection successfully treated with ribavirin.
    Stephen EL; Jahrling PB
    Lancet; 1979 Feb; 1(8110):268-9. PubMed ID: 84919
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative evaluation of the antiviral efficacy of virazole and ribamidil in experimental Lassa fever in monkeys].
    Dvoretskaia VI; Evseev AA; Bogatikov GV; Pshenichnov VA
    Vopr Virusol; 1990; 35(2):151-2. PubMed ID: 2389569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribavirin therapy for lassa fever.
    Snell N
    Practitioner; 1988 Apr; 232(1447):432. PubMed ID: 3249720
    [No Abstract]   [Full Text] [Related]  

  • 5. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin.
    Jahrling PB; Hesse RA; Eddy GA; Johnson KM; Callis RT; Stephen EL
    J Infect Dis; 1980 May; 141(5):580-9. PubMed ID: 6768812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys.
    Jahrling PB; Peters CJ; Stephen EL
    J Infect Dis; 1984 Mar; 149(3):420-7. PubMed ID: 6715898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lassa fever. Effective therapy with ribavirin.
    McCormick JB; King IJ; Webb PA; Scribner CL; Craven RB; Johnson KM; Elliott LH; Belmont-Williams R
    N Engl J Med; 1986 Jan; 314(1):20-6. PubMed ID: 3940312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental Lassa infection in monkeys and its treatment with ribamidil].
    Fidarov FM; Sabynin VM; Petkevich AS; Surikova LE; Vladyko AS; Lukashevich IS
    Vopr Virusol; 1990; 35(6):504-6. PubMed ID: 2082557
    [No Abstract]   [Full Text] [Related]  

  • 9. Time to reconsider the role of ribavirin in Lassa fever.
    Salam AP; Cheng V; Edwards T; Olliaro P; Sterne J; Horby P
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009522. PubMed ID: 34237063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The therapeutic efficacy of ribamidil and virazole in experimental Lassa fever in monkeys].
    Dvoretskaia VI; Bogatikov GV; Pshenichnov VA; Evseev AA
    Vopr Virusol; 1991; 36(1):55-7. PubMed ID: 1858356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronotoxicity of mizoribine under repeated administration in the rat.
    Hishikawa S; To H; Kobayashi E; Uchida H; Fujimura A
    Transplant Proc; 1999 Nov; 31(7):2765-6. PubMed ID: 10578283
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic study of platelets and fibrinogen in Lassa virus-infected monkeys and early pathologic events in Mopeia virus-infected monkeys.
    Lange JV; Mitchell SW; McCormick JB; Walker DH; Evatt BL; Ramsey RR
    Am J Trop Med Hyg; 1985 Sep; 34(5):999-1007. PubMed ID: 4037187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.
    Bausch DG; Hadi CM; Khan SH; Lertora JJ
    Clin Infect Dis; 2010 Dec; 51(12):1435-41. PubMed ID: 21058912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.
    Oestereich L; Rieger T; Lüdtke A; Ruibal P; Wurr S; Pallasch E; Bockholt S; Krasemann S; Muñoz-Fontela C; Günther S
    J Infect Dis; 2016 Mar; 213(6):934-8. PubMed ID: 26531247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic dysfunction in Lassa fever.
    Fisher-Hoch S; McCormick JB; Sasso D; Craven RB
    J Med Virol; 1988 Oct; 26(2):127-35. PubMed ID: 3183637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
    Safronetz D; Rosenke K; Westover JB; Martellaro C; Okumura A; Furuta Y; Geisbert J; Saturday G; Komeno T; Geisbert TW; Feldmann H; Gowen BB
    Sci Rep; 2015 Oct; 5():14775. PubMed ID: 26456301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria.
    Groger M; Akhideno P; Kleist CJ; Babatunde FO; Edeawe O; Hinzmann J; Akhigbe T; Nwatuzor J; Eifediyi G; Müller J; Hinrichs M; Pahlmann M; Sarpong FN; Wagner C; Thielebein A; Aihonwalan L; Koch T; Riedner M; Ogbaini-Emovon E; Okogbenin S; Günther S; Wicha SG; Ramharter M; Oestereich L; Duraffour S; Erameh C
    Clin Infect Dis; 2023 Feb; 76(3):e841-e848. PubMed ID: 35881530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever.
    Fisher-Hoch SP; Mitchell SW; Sasso DR; Lange JV; Ramsey R; McCormick JB
    J Infect Dis; 1987 Mar; 155(3):465-74. PubMed ID: 3543155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection.
    Smith CB; Charette RP; Fox JP; Cooney MK; Hall CE
    J Infect Dis; 1980 May; 141(5):548-54. PubMed ID: 7373088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological and bone marrow effects of ribavirin in rhesus monkeys.
    Canonico PG; Kastello MD; Cosgriff TM; Donovan JC; Ross PE; Spears CT; Stephen EL
    Toxicol Appl Pharmacol; 1984 Jun; 74(2):163-72. PubMed ID: 6740667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.